Clinical and research tests for C1843028 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 38

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
CentoCardio Panel Centogene US, LLC - The Rare Disease Company United States	289	275	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoHear Panel Centogene US, LLC - The Rare Disease Company United States	203	194	D Deletion/duplication analysis C Sequence analysis of the entire coding region
MYO6 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
MYO6 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoCardio Panel Centogene AG - the Rare Disease Company Germany	289	275	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CentoHear Panel Centogene AG - the Rare Disease Company Germany	203	194	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Comprehensive Deafness Panel Invitae United States	405	219	D Deletion/duplication analysis
OtoSCOPE v9 Molecular Otolaryngology and Renal Research Laboratories University of Iowa Hospital and Clinics United States	288	218	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Deafness, autosomal recessive 37, 607821, Autosomal recessive; DFNB37 (Autosomal recessive non-syndromic sensorineural deafness type DFNB) (MYO6 gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Genetic Diagnosis and Research Centre Turkey	1	1	C Sequence analysis of the entire coding region
Hereditary Hearing Loss and Deafness Panel PreventionGenetics United States	356	209	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Deafness, Autosomal Dominant 22 (DFNA22) and Deafness, Autosomal Recessive 37 (DFNB37) via the MYO6 Gene PreventionGenetics United States	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Autosomal Dominant Hearing Loss. 25-gene NGS panel. Genologica Medica Spain	48	23	C Sequence analysis of the entire coding region
Non-syndromic hearing loss panel. 95-gene NGS panel. Genologica Medica Spain	146	94	C Sequence analysis of the entire coding region
Autosomal recessive hearing loss. 41-gene NGS panel. Genologica Medica Spain	65	41	C Sequence analysis of the entire coding region
Sudden death (WES based NGS panel of 83 genes, including CNV analysis) Unilabs Genetics CGC Genetics Portugal	172	80	C Sequence analysis of the entire coding region
Hypertrophic cardiomyopathy (WES based NGS panel of 68 genes, including CNV analysis) Unilabs Genetics CGC Genetics Portugal	150	68	C Sequence analysis of the entire coding region
Cardiomyopathy (hypertrophic, dilated , arrhythmogenic right ventricular dysplasia and left ventricular noncompaction) and changes in cardiac conduction (WES based NGS panel of 140 genes, including CNV analysis) Unilabs Genetics CGC Genetics Portugal	268	140	C Sequence analysis of the entire coding region
Deafness, autosomal dominant 22 (sequence analysis of MYO6 gene) Unilabs Genetics CGC Genetics Portugal	2	1	C Sequence analysis of the entire coding region
Deafness, autosomal recessive 37 (deletion/duplication analysis on MYO6 gene) Unilabs Genetics CGC Genetics Portugal	2	1	D Deletion/duplication analysis
Hearing Loss, Comprehensive Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States	142	84	C Sequence analysis of the entire coding region

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 38

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.